These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 26668132

  • 1. The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunity.
    Chen Y, Schroeder JA, Chen J, Luo X, Baumgartner CK, Montgomery RR, Hu J, Shi Q.
    Blood; 2016 Mar 10; 127(10):1346-54. PubMed ID: 26668132
    [Abstract] [Full Text] [Related]

  • 2. The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity.
    Chen J, Schroeder JA, Luo X, Montgomery RR, Shi Q.
    J Thromb Haemost; 2019 Mar 10; 17(3):449-459. PubMed ID: 30609275
    [Abstract] [Full Text] [Related]

  • 3. Platelet VIII pack evades immune detection.
    Ragni MV.
    Blood; 2016 Mar 10; 127(10):1222-4. PubMed ID: 26965921
    [Abstract] [Full Text] [Related]

  • 4. The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies.
    Shi Q, Schroeder JA, Kuether EL, Montgomery RR.
    J Thromb Haemost; 2015 Jul 10; 13(7):1301-9. PubMed ID: 25955153
    [Abstract] [Full Text] [Related]

  • 5. Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity.
    Shi Q, Fahs SA, Wilcox DA, Kuether EL, Morateck PA, Mareno N, Weiler H, Montgomery RR.
    Blood; 2008 Oct 01; 112(7):2713-21. PubMed ID: 18495954
    [Abstract] [Full Text] [Related]

  • 6. Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated.
    Chen Y, Luo X, Schroeder JA, Chen J, Baumgartner CK, Hu J, Shi Q.
    J Thromb Haemost; 2017 Oct 01; 15(10):1994-2004. PubMed ID: 28799202
    [Abstract] [Full Text] [Related]

  • 7. Pre-existing anti-factor VIII immunity alters therapeutic platelet-targeted factor VIII engraftment following busulfan conditioning through cytotoxic CD8 T cells.
    Jing W, Baumgartner CK, Xue F, Schroeder JA, Shi Q.
    J Thromb Haemost; 2023 Mar 01; 21(3):488-498. PubMed ID: 36696197
    [Abstract] [Full Text] [Related]

  • 8. Comparison of platelet-derived and plasma factor VIII efficacy using a novel native whole blood thrombin generation assay.
    Baumgartner CK, Zhang G, Kuether EL, Weiler H, Shi Q, Montgomery RR.
    J Thromb Haemost; 2015 Dec 01; 13(12):2210-9. PubMed ID: 26453193
    [Abstract] [Full Text] [Related]

  • 9. Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-factor VIII immunity.
    Kuether EL, Schroeder JA, Fahs SA, Cooley BC, Chen Y, Montgomery RR, Wilcox DA, Shi Q.
    J Thromb Haemost; 2012 Aug 01; 10(8):1570-80. PubMed ID: 22632092
    [Abstract] [Full Text] [Related]

  • 10. Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A.
    Shi Q, Wilcox DA, Fahs SA, Fang J, Johnson BD, DU LM, Desai D, Montgomery RR.
    J Thromb Haemost; 2007 Feb 01; 5(2):352-61. PubMed ID: 17269937
    [Abstract] [Full Text] [Related]

  • 11. Platelet-Targeted FVIII Gene Therapy Restores Hemostasis and Induces Immune Tolerance for Hemophilia A.
    Cai Y, Shi Q.
    Front Immunol; 2020 Feb 01; 11():964. PubMed ID: 32595633
    [Abstract] [Full Text] [Related]

  • 12. In vivo enrichment of genetically manipulated platelets corrects the murine hemophilic phenotype and induces immune tolerance even using a low multiplicity of infection.
    Schroeder JA, Chen Y, Fang J, Wilcox DA, Shi Q.
    J Thromb Haemost; 2014 Aug 01; 12(8):1283-93. PubMed ID: 24931217
    [Abstract] [Full Text] [Related]

  • 13. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.
    Shi Q, Wilcox DA, Fahs SA, Weiler H, Wells CW, Cooley BC, Desai D, Morateck PA, Gorski J, Montgomery RR.
    J Clin Invest; 2006 Jul 01; 116(7):1974-82. PubMed ID: 16823491
    [Abstract] [Full Text] [Related]

  • 14. Modification of an exposed loop in the C1 domain reduces immune responses to factor VIII in hemophilia A mice.
    Wroblewska A, van Haren SD, Herczenik E, Kaijen P, Ruminska A, Jin SY, Zheng XL, van den Biggelaar M, ten Brinke A, Meijer AB, Voorberg J.
    Blood; 2012 May 31; 119(22):5294-300. PubMed ID: 22498747
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of the Thrombus Formation in Transgenic Mice with Platelet-Targeted Factor VIII Expression.
    Wang Y, Mao J, Li L, Xiao B, Ruan Z, Liu Y, Zhang G, Wang D, Mi JQ, Fang C, Xi X, Shi X, Wang J.
    Thromb Haemost; 2022 May 31; 122(5):755-766. PubMed ID: 34587639
    [Abstract] [Full Text] [Related]

  • 16. B cell-activating factor modulates the factor VIII immune response in hemophilia A.
    Doshi BS, Rana J, Castaman G, Shaheen MA, Kaczmarek R, Butterfield JS, Meeks SL, Leissinger C, Biswas M, Arruda VR.
    J Clin Invest; 2021 Apr 15; 131(8):. PubMed ID: 33651716
    [Abstract] [Full Text] [Related]

  • 17. A Retrospective Study of the Cytokine Profile Changes in Mice with FVIII Inhibitor Development After Adeno-Associated Virus-Mediated Gene Therapy in a Hemophilia A Mouse Model.
    Sun J, Yuan Z, Abajas YL, Szollosi DE, Hu G, Hua B, Xiao X, Li C.
    Hum Gene Ther; 2018 Mar 15; 29(3):381-389. PubMed ID: 28922951
    [Abstract] [Full Text] [Related]

  • 18. Ectopic Expression of FVIII in HPCs and MSCs Derived from hiPSCs with Site-Specific Integration of ITGA2B Promoter-Driven BDDF8 Gene in Hemophilia A.
    Zhao J, Zhou M, Wang Z, Wu L, Hu Z, Liang D.
    Int J Mol Sci; 2022 Jan 06; 23(2):. PubMed ID: 35054807
    [Abstract] [Full Text] [Related]

  • 19. Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A.
    Lai JD, Moorehead PC, Sponagle K, Steinitz KN, Reipert BM, Hough C, Lillicrap D.
    Blood; 2016 Jun 30; 127(26):3439-49. PubMed ID: 27034428
    [Abstract] [Full Text] [Related]

  • 20. Von Willebrand factor-specific antibodies developing upon treatment of FVIII-deficient mice with different FVIII preparations.
    Kallas A, Kuuse S, Maimets T, Pooga M.
    Acta Haematol; 2008 Jun 30; 119(4):244-7. PubMed ID: 18594135
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.